Literature DB >> 1433211

Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines.

A Malabarba1, R Ciabatti, J Kettenring, R Scotti, G Candiani, R Pallanza, M Berti, B P Goldstein.   

Abstract

Basic carboxamides of teicoplanin A2 (CTA) and its aglycon (TD) are prepared by condensation of the 63-carboxyl function of these antibiotics with linear or branched polyamines. The antimicrobial activities of some of the resulting compounds were better than those of the unmodified antibiotics. The presence of more than one basic group in the amidic chain enhanced the in vitro activity of some TD-amides against Gram-negative bacteria; two of these derivatives were also effective in vivo against Escherichia coli septicemia in the mouse. Among the CTA derivatives, the amide with spermine showed some unexpected in vitro activity against Gram-negatives. Both CTA- and TD-amides with polyamines are very soluble in water over a wide range of pH and are very hydrophilic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433211     DOI: 10.1021/jm00100a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.

Authors:  K Leszczyńska; A Namiot; K Cruz; F J Byfield; E Won; G Mendez; W Sokołowski; P B Savage; R Bucki; P A Janmey
Journal:  J Appl Microbiol       Date:  2010-10-21       Impact factor: 3.772

2.  Mechanism of uptake of deglucoteicoplanin amide derivatives across outer membranes of Escherichia coli and Pseudomonas aeruginosa.

Authors:  R E Hancock; S W Farmer
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

3.  Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.

Authors:  Katarzyna Leszczynska; Dorota Namiot; Fitzroy J Byfield; Katrina Cruz; Malgorzata Zendzian-Piotrowska; David E Fein; Paul B Savage; Scott Diamond; Christopher A McCulloch; Paul A Janmey; Robert Bucki
Journal:  J Antimicrob Chemother       Date:  2012-11-07       Impact factor: 5.790

4.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.